| Literature DB >> 17343719 |
Claudia Stöllberger1, Birke Schneider, Josef Finsterer.
Abstract
Left atrial appendage (LAA) elimination is regarded to protect patients with atrial fibrillation (AF) from stroke or embolism. The Watchman occluder is a device for percutaneous LAA occlusion and is at present investigated in the PROTECT AF trial. In a 78-year-old man, embolization of the Watchman device occurred 10 minutes after implantation. At emergency cardiac surgery, the device was removed from the aortic valve and an aortic bioprosthesis and a pacemaker had to be implanted. One year postoperatively, he still suffers from heart failure. This case shows that percutaneous LAA occlusion may result in serious complications.Entities:
Mesh:
Year: 2007 PMID: 17343719 DOI: 10.1111/j.1540-8167.2007.00784.x
Source DB: PubMed Journal: J Cardiovasc Electrophysiol ISSN: 1045-3873